FRISCO, Texas, April 12, 2018 -- Integer Holdings Corporation (NYSE:ITGR), announced today that it plans to release financial and operational results for first quarter 2018, after market close on Thursday, May 3, 2018. Following the release, Integer management will host a conference call with a live webcast to discuss these results. Other forward-looking and material information may also be discussed during this call.
Conference call details:
- Date: Thursday, May 3, 2018
- Time: 5:00 p.m. ET / 4:00 p.m. CT
- Domestic dial-in number: 1-866-393-4306
- International dial-in number: 1-734-385-2616
- Conference ID: 3567829
The conference call webcast and subsequent archived replay may be accessed via the following link: https:investor.integer.net.
About Integer™
Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device outsource (MDO) manufacturers in the world serving the cardiac, neuromodulation, orthopedics, vascular, advanced surgical and portable medical markets. The company provides innovative, high-quality medical technologies that enhance the lives of patients worldwide. In addition, it develops batteries for high-end niche applications in energy, military, and environmental markets. The company's brands include GreatbatchTM Medical, Lake Region MedicalTM and ElectrochemTM. Additional information is available at www.integer.net.
Investor Relations:
Amy Wakeham
[email protected]
214.618.4978
Media Relations:
Kelly Butler
[email protected]
214.618.4216


Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat
Jefferies Names AMEC Top China Semiconductor Equipment Pick
Google Changes EU Spam Policy Amid Antitrust Scrutiny
Meta, U.S. States Discuss Settlement in Teen Addiction Trial
Toyota Global Sales Fall as China Demand Slumps
Honda, Nissan Eye Shared Vehicle Software Platform by 2029
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14%
Mercer International Stock Surges 45% on C$20 Million Canada Funding
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question
Trump Administration Plans New Drug Pricing Deals With Biotech Firms
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Amazon Secures 200 MW Wind Power Deals in Sweden
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 



